GW1929: A nonthiazolidinedione PPARγ agonist, ameliorates neurological damage in global cerebral ischemic-reperfusion injury through reduction in inflammation and DNA fragmentation

Behavioural Brain Research

Volumn 216, Issue 2, 2011, Pages 606-612

  Kaundal, Ravinder K ^a   Sharma, Shyam Sunder ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Global cerebral IR injury; GW1929; Hippocampal damage; Histology; Neurobehavioral deficits; PPAR; TUNEL

Indexed keywords

DNA; GELATINASE B; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; N (2 BENZOYLPHENYL) O [2 (METHYL 2 PYRIDINYLAMINO)ETHYL]TYROSINE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DAMAGE; BRAIN ISCHEMIA; CAROTID ARTERY OBSTRUCTION; COGNITIVE DEFECT; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG MECHANISM; GERBIL; HIPPOCAMPUS; HISTOPATHOLOGY; IMMUNOREACTIVITY; INFLAMMATION; LOCOMOTION; MALE; NERVE DEGENERATION; NEUROPROTECTION; NICK END LABELING; NONHUMAN; PASSIVE AVOIDANCE; PRIORITY JOURNAL; REPERFUSION INJURY; RISK REDUCTION;

ANALYSIS OF VARIANCE; ANIMALS; BENZOPHENONES; BRAIN DAMAGE, CHRONIC; BRAIN ISCHEMIA; COGNITION DISORDERS; DNA FRAGMENTATION; GERBILLINAE; HIPPOCAMPUS; MALE; MOTOR ACTIVITY; NEUROPROTECTIVE AGENTS; PPAR GAMMA; REPERFUSION INJURY; TYROSINE;

EID: 78149497492     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2010.09.001     Document Type: Article

References (42)

1. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 1982, 239:57-69.
2. Dillon G.M., Qu X., Marcus J.N., Dodart J.C. Excitotoxic lesions restricted to the dorsal CA1 field of the hippocampus impair spatial memory and extinction learning in C57BL/6 mice. Neurobiol Learn Mem 2008, 90:426-433.
3. Broughton B.R., Reutens D.C., Sobey C.G. Apoptotic mechanisms after cerebral ischemia. Stroke 2009, 40:e331-e339.
4. Kirino T. Delayed neuronal death. Neuropathology 2000, 20(Suppl):S95-S97.
5. Krause G.S., White B.C., Aust S.D., Nayini N.R., Kumar K. Brain cell death following ischemia and reperfusion: a proposed biochemical sequence. Crit Care Med 1988, 16:714-726.
6. Mitani A., Andou Y., Kataoka K. Selective vulnerability of hippocampal CA1 neurons cannot be explained in terms of an increase in glutamate concentration during ischemia in the gerbil: brain microdialysis study. Neuroscience 1992, 48:307-313.
7. Nitatori T., Sato N., Waguri S., Karasawa Y., Araki H., Shibanai K., et al. Delayed neuronal death in the CA1 pyramidal cell layer of the gerbil hippocampus following transient ischemia is apoptosis. J Neurosci 1995, 15:1001-1011.
8. Sharma S.S., Thiyagarajan M. Molecular mechanisms of cerebral ischemia. Molecular and cellular neurobiology 2005, 191-202. Narosa Publishing House, New Delhi. M.K. Thakur, S. Prasad (Eds.).
9. Harukuni I., Bhardwaj A. Mechanisms of brain injury after global cerebral ischemia. Neurol Clin 2006, 24:1-21.
10. Kumar K. Cerebral ischemia, mechanisms and therapeutic approaches-current status. Curr Opin Investig Drugs 2006, 7:595-599.
11. Nakka V.P., Gusain A., Mehta S.L., Raghubir R. Molecular mechanisms of apoptosis in cerebral ischemia: multiple neuroprotective opportunities. Mol Neurobiol 2008, 37:7-38.
12. Culman J., Zhao Y., Gohlke P., Herdegen T. PPAR-gamma: therapeutic target for ischemic stroke. Trends Pharmacol Sci 2007, 28:244-249.
13. Collino M., Aragno M., Mastrocola R., Gallicchio M., Rosa A.C., Dianzani C., et al. Modulation of the oxidative stress and inflammatory response by PPAR-gamma agonists in the hippocampus of rats exposed to cerebral ischemia/reperfusion. Eur J Pharmacol 2006, 530:70-80.
14. Kaundal R.K., Iyer S., Kumar A., Sharma S.S. Protective effects of pioglitazone against global cerebral ischemic-reperfusion injury in gerbils. J Pharmacol Sci 2009, 109:361-367.
15. Tureyen K., Kapadia R., Bowen K.K., Satriotomo I., Liang J., Feinstein D.L., et al. Peroxisome proliferator-activated receptor-gamma agonists induce neuroprotection following transient focal ischemia in normotensive, normoglycemic as well as hypertensive and type-2 diabetic rodents. J Neurochem 2007, 101:41-56.
16. Sundararajan S., Gamboa J.L., Victor N.A., Wanderi E.W., Lust W.D., Landreth G.E. Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia. Neuroscience 2005, 130:685-696.
17. McGraw C.P. Experimental cerebral infarctioneffects of pentobarbital in Mongolian gerbils. Arch Neurol 1977, 34:334-336.
18. Dhar A., Kaundal R.K., Sharma S.S. Neuroprotective effects of FeTMPyP, a peroxynitrite decomposition catalyst in global cerebral ischemia model in gerbils. Pharmacol Res 2006, 54:311-316.
19. Sharma S.S., Dhar A., Kaundal R.K. FeTPPS protects against global cerebral ischemic-reperfusion injury in gerbils. Pharmacol Res 2007, 55:335-342.
20. Bassetti C., Bomio F., Mathis J., Hess C.W. Early prognosis in coma after cardiac arrest: a prospective clinical, electrophysiological, and biochemical study of 60 patients. J Neurol Neurosurg Psychiatry 1996, 61:610-615.
21. Petito C.K., Feldmann E., Pulsinelli W.A., Plum F. Delayed hippocampal damage in humans following cardiorespiratory arrest. Neurology 1987, 37:1281-1286.
22. Lim C., Alexander M.P., LaFleche G., Schnyer D.M., Verfaellie M. The neurological and cognitive sequelae of cardiac arrest. Neurology 2004, 63:1774-1778.
23. Gupta S., Sharma S.S. Neuroprotective effects of Trolox in global cerebral ischemia in gerbils. Biol Pharm Bull 2006, 29:957-961.
24. Block F., Schwarz M. Correlation between hippocampal neuronal damage and spatial learning deficit due to global ischemia. Pharmacol Biochem Behav 1997, 56:755-761.
25. Sharma S.S., Gupta S. Neuroprotective effect of MnTMPyP, a superoxide dismutase/catalase mimetic in global cerebral ischemia is mediated through reduction of oxidative stress and DNA fragmentation. Eur J Pharmacol 2007, 561:72-79.
26. Wang D., Corbett D. Cerebral ischemia, locomotor activity and spatial mapping. Brain Res 1990, 533:78-82.
27. Kumar P., Kaundal R.K., More S., Sharma S.S. Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease. Behav Brain Res 2009, 197:398-403.
28. Glatz T., Stock I., Nguyen-Ngoc M., Gohlke P., Herdegen T., Culman J., et al. Peroxisome-proliferator-activated receptors gamma and peroxisome-proliferator-activated receptors beta/delta and the regulation of interleukin 1 receptor antagonist expression by pioglitazone in ischaemic brain. J Hypertens 2010, 28:1488-1497.
29. Lee S.R., Kim H.Y., Hong J.S., Baek W.K., Park J.W. PPARgamma agonist pioglitazone reduces matrix metalloproteinase-9 activity and neuronal damage after focal cerebral ischemia. Biochem Biophys Res Commun 2009, 380:17-21.
30. Zhao Y., Patzer A., Herdegen T., Gohlke P., Culman J. Activation of cerebral peroxisome proliferator-activated receptors gamma promotes neuroprotection by attenuation of neuronal cyclooxygenase-2 overexpression after focal cerebral ischemia in rats. FASEB J 2006, 20:1162-1175.
31. Kaundal R.K., Sharma S.S. Peroxisome proliferator-activated receptor gamma agonists as neuroprotective agents. Drug News Perspect 2010, 23:241-256.
32. Wang X., Yue T.L., Young P.R., Barone F.C., Feuerstein G.Z. Expression of interleukin-6, c-fos, and zif268 mRNAs in rat ischemic cortex. J Cereb Blood Flow Metab 1995, 15:166-171.
33. Patzer A., Zhao Y., Stock I., Gohlke P., Herdegen T., Culman J. Peroxisome proliferator-activated receptorsgamma (PPARgamma) differently modulate the interleukin-6 expression in the peri-infarct cortical tissue in the acute and delayed phases of cerebral ischaemia. Eur J Neurosci 2008, 28:1786-1794.
34. Huang J., Upadhyay U.M., Tamargo R.J. Inflammation in stroke and focal cerebral ischemia. Surg Neurol 2006, 66:232-245.
35. Wang Q., Tang X.N., Yenari M.A. The inflammatory response in stroke. J Neuroimmunol 2007, 184:53-68.
36. Sei Y., Von Lubitz K.J., Basile A.S., Borner M.M., Lin R.C., Skolnick P., et al. Internucleosomal DNA fragmentation in gerbil hippocampus following forebrain ischemia. Neurosci Lett 1994, 171:179-182.
37. Sharma S.S., Kaundal R.K. Neuroprotective effects of 6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid (trolox), an antioxidant in middle cerebral artery occlusion induced focal cerebral ischemia in rats. Neurol Res 2007, 29:304-309.
38. Kaundal R.K., Shah K.K., Sharma S.S. Neuroprotective effects of NU1025, a PARP inhibitor in cerebral ischemia are mediated through reduction in NAD depletion and DNA fragmentation. Life Sci 2006, 79:2293-2302.
39. Chu K., Lee S.T., Koo J.S., Jung K.H., Kim E.H., Sinn D.I., et al. Peroxisome proliferator-activated receptor-gamma-agonist, rosiglitazone, promotes angiogenesis after focal cerebral ischemia. Brain Res 2006, 1093:208-218.
40. Wu J.S., Cheung W.M., Tsai Y.S., Chen Y.T., Fong W.H., Tsai H.D., et al. Ligand-activated peroxisome proliferator-activated receptor-gamma protects against ischemic cerebral infarction and neuronal apoptosis by 14-3-3 epsilon upregulation. Circulation 2009, 119:1124-1134.
41. Pei L., Zhang Y., Chu X., Zhang J., Wang R., Liu M., et al. Peroxisome proliferator-activated receptor gamma promotes neuroprotection by modulating cyclic D1 expression after focal cerebral ischemia. Can J Physiol Pharmacol 2010, 88:716-723.
42. Fong W.H., Tsai H.D., Chen Y.C., Wu J.S., Lin T.N. Anti-apoptotic actions of PPAR-gamma against ischemic stroke. Mol Neurobiol 2010, 41:180-186.